CSB has been named as one of the NCI Innovative Research in Cancer Nanotechnology (IRCNs). The IRCNs engage in directed, product-focused research that aims to translate cutting-edge science and technology into the next generation of diagnostic and therapeutic tools. These platforms serve as the core technologies for a wide array of specific applications that will ultimately benefit cancer patients.
Jouha Min, PhD (Weissleder Lab) received the Masoumeh Ghaderi Prize for Best Sound-Bite Presentation (1st Place) at the 5th Annual Workshop on Micro- and Nanotechnologies for Medicine: Emerging Frontiers and Applications.
Sean Arlauckas of the Weissleder lab won the Tayyaba Hasan, PhD ORCD Poster of Prestige Award for top abstract at this year’s MGH Research Fellow Poster Celebration. The prize recognizes outstanding contributions to the MGH research enterprise.
"It happens every day, in exam rooms across the country, something that would have been unthinkable 20 years ago: Doctors and nurses turn away from their patients and focus their attention elsewhere — on their computer screens......" - WBUR Commentary
Miles Miller, PhD and Kevin King, MD, PhD have been selected to serve as Associate Scientific Advisors (ASAs) for Science's sister journal, Science Translational Medicine, for 2017-2018.